Myriad Genetics (MYGN) News Today $11.56 -0.18 (-1.53%) Closing price 04:00 PM EasternExtended Trading$11.56 0.00 (0.00%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Myriad Genetics price target lowered to $19 from $27 at Raymond JamesFebruary 26 at 7:39 AM | markets.businessinsider.comPiper Sandler Keeps Their Hold Rating on Myriad Genetics (MYGN)February 26 at 2:38 AM | markets.businessinsider.comMyriad Genetics (MYGN) Receives a Buy from Craig-HallumFebruary 26 at 2:38 AM | markets.businessinsider.comMyriad Genetics, Inc. (MYGN): AI-Driven Precision Medicine for Prostate CancerFebruary 26 at 2:38 AM | msn.comWhy Myriad Genetics (MYGN) Shares Are Plunging TodayFebruary 26 at 2:38 AM | msn.comMyriad Genetics Faces Cost Restructuring As UnitedHealthcare Ends GeneSight Coverage, Appoints New CEOFebruary 25 at 3:02 PM | benzinga.comMyriad Genetics (NASDAQ:MYGN) Receives Outperform Rating from Raymond JamesRaymond James reissued an "outperform" rating and issued a $19.00 price target (down previously from $27.00) on shares of Myriad Genetics in a research report on Tuesday.February 25 at 12:41 PM | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Price Target Lowered to $16.00 at UBS GroupUBS Group dropped their target price on Myriad Genetics from $18.00 to $16.00 and set a "neutral" rating for the company in a report on Tuesday.February 25 at 10:45 AM | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Sets New 52-Week Low Following Weak EarningsMyriad Genetics (NASDAQ:MYGN) Sets New 1-Year Low Following Weak EarningsFebruary 25 at 10:17 AM | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Releases Earnings Results, Misses Expectations By $0.12 EPSMyriad Genetics (NASDAQ:MYGN - Get Free Report) issued its earnings results on Monday. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.12). The company had revenue of $210.60 million during the quarter, compared to analyst estimates of $210.35 million. Myriad Genetics had a negative return on equity of 4.51% and a negative net margin of 14.09%. During the same period in the prior year, the business earned ($0.12) earnings per share.February 25 at 9:48 AM | marketbeat.comCautious Outlook for Myriad Genetics Amid Leadership Transition and Revised Growth ProjectionsFebruary 25 at 9:28 AM | tipranks.comMyriad Genetics, Inc. (NASDAQ:MYGN) Q4 2024 Earnings Call TranscriptFebruary 25 at 9:04 AM | insidermonkey.comMyriad Genetics Inc (MYGN) Announces Leadership Transition with New CEO and COO AppointmentsFebruary 25 at 6:49 AM | gurufocus.comMyriad Genetics Inc (MYGN) Reports Strong Q4 2024 Results and Strategic DevelopmentsFebruary 25 at 6:49 AM | gurufocus.comMyriad Genetics Inc (MYGN) Partners with PATHOMIQ for AI-Driven Prostate Cancer DiagnosticsFebruary 25 at 3:30 AM | gurufocus.comMyriad Genetics Inc (MYGN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...February 25 at 2:21 AM | gurufocus.comQ4 2024 Myriad Genetics Inc Earnings Call TranscriptFebruary 25 at 12:17 AM | gurufocus.comMyriad Genetics CEO Paul Diaz to Return to Cressey & Co.February 25 at 12:15 AM | marketwatch.comMyriad Genetics Shares Fall, Company Reports Earnings and CEO ChangeFebruary 25 at 12:15 AM | marketwatch.comMyriad Genetics sees FY25 adjusted EPS 7c-11c, consensus 6cFebruary 25 at 12:15 AM | markets.businessinsider.comMyriad Genetics CEO Paul Diaz to depart, Sam Raha to succeedFebruary 25 at 12:15 AM | markets.businessinsider.comMyriad Genetics Announces Senior Leadership TransitionFebruary 25 at 12:15 AM | finance.yahoo.comMyriad Genetics (NASDAQ:MYGN) Misses Q4 Sales Targets, Stock DropsFebruary 25 at 12:15 AM | msn.comMyriad Genetics, Inc. (MYGN) Q4 2024 Earnings Call TranscriptFebruary 24 at 8:33 PM | seekingalpha.comMyriad Genetics Reports Q4 Revenue of $211 Million, Slightly Missing Estimates; EPS Aligns with ...February 24 at 5:15 PM | gurufocus.comMyriad Genetics Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-year 2024 revenue of $838 million grew 11% year-over-year, the second consecutive year of double-digit revenue growthFebruary 24 at 4:05 PM | globenewswire.comMyriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to ...February 24 at 9:09 AM | gurufocus.comMyriad Genetics and PATHOMIQ Announce Strategic Collaboration to Enhance AI-Enabled Prostate Cancer DiagnosticsFebruary 24 at 9:09 AM | quiverquant.comMyriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology PortfolioFebruary 24 at 8:30 AM | globenewswire.comMyriad Genetics (MYGN) Expected to Announce Quarterly Earnings on TuesdayFebruary 24 at 1:42 AM | americanbankingnews.comWhat To Expect From Myriad Genetics’s (MYGN) Q4 EarningsFebruary 23 at 5:42 PM | msn.comStockNews.com Downgrades Myriad Genetics (NASDAQ:MYGN) to HoldStockNews.com lowered Myriad Genetics from a "buy" rating to a "hold" rating in a research report on Thursday.February 22, 2025 | marketbeat.comPeregrine Capital Management LLC Boosts Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)Peregrine Capital Management LLC boosted its position in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 12.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 342,845 shares of the company's stFebruary 20, 2025 | marketbeat.comMyriad Genetics Included in Forbes America’s Best Employers 2025 ListFebruary 19, 2025 | markets.businessinsider.comMyriad Genetics Included in Forbes America's Best Employers 2025 ListFebruary 19, 2025 | globenewswire.comMyriad Genetics (MYGN) to Release Quarterly Earnings on TuesdayMyriad Genetics (NASDAQ:MYGN) will be releasing earnings before the market opens on Tuesday, February 25, Financial Modeling Prep reports.February 18, 2025 | marketbeat.com3 Reasons to Sell MYGN and 1 Stock to Buy InsteadFebruary 18, 2025 | finance.yahoo.comMyriad Genetics (NASDAQ:MYGN) Trading Up 8.3% - Still a Buy?Myriad Genetics (NASDAQ:MYGN) Shares Up 8.3% - Still a Buy?February 14, 2025 | marketbeat.comCraig-Hallum Initiates Coverage of Myriad Genetics (MYGN) with Buy RecommendationFebruary 13, 2025 | msn.comCraig-Hallum bulish on Myriad Genetics, initiates with a BuyFebruary 12, 2025 | markets.businessinsider.comMyriad Genetics initiated with a Buy at Craig-HallumFebruary 12, 2025 | markets.businessinsider.comCraig Hallum Begins Coverage on Myriad Genetics (NASDAQ:MYGN)Craig Hallum initiated coverage on shares of Myriad Genetics in a research report on Wednesday. They issued a "buy" rating and a $29.00 target price on the stock.February 12, 2025 | marketbeat.comMyriad Genetics, Inc. (NASDAQ:MYGN) Given Average Recommendation of "Hold" by AnalystsShares of Myriad Genetics, Inc. (NASDAQ:MYGN - Get Free Report) have received a consensus rating of "Hold" from the thirteen analysts that are covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, seven have assigned a holFebruary 10, 2025 | marketbeat.comMyriad Genetics, Inc.: Myriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer TestFebruary 7, 2025 | finanznachrichten.deMyriad Genetics, Inc.: Myriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) AssayFebruary 7, 2025 | finanznachrichten.deMyriad Genetics, CancerCARE for Life announce agreementFebruary 7, 2025 | markets.businessinsider.comMyriad Genetics, INTERLINK Partner To Enhance Access To Hereditary Cancer TestingFebruary 7, 2025 | markets.businessinsider.comJennison Associates LLC Raises Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)Jennison Associates LLC boosted its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 144.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 59,015 shares of the company's stock after acquiring an additiFebruary 7, 2025 | marketbeat.comMyriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer TestFebruary 6, 2025 | globenewswire.comMyriad Genetics announce collab with LumeaFebruary 6, 2025 | markets.businessinsider.com Get Myriad Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for MYGN and its competitors with MarketBeat's FREE daily newsletter. Email Address MYGN Media Mentions By Week MYGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MYGN News Sentiment▼0.130.51▲Average Medical News Sentiment MYGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MYGN Articles This Week▼367▲MYGN Articles Average Week Get Myriad Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for MYGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FOLD News LGND News DVAX News BCRX News MNKD News GERN News CLDX News NVAX News OPK News INVA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MYGN) was last updated on 2/26/2025 by MarketBeat.com Staff From Our PartnersThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThe U.S. is About to Run Out of Money… Again.Treasury Warns America is Nearing Bankruptcy Discover the harmful impact on your retirement savings… True Gold Republic | SponsoredTop Picks for Trump’s Pro-Crypto America10,000% Crypto Opportunities in 2025 27 of the brightest minds in crypto share exclusive intel… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWall St Icon: Nvidia could 10x, but THIS could 100xI've identified a small chip maker that reminds me so much of early-stage Nvidia, it stopped me in my tracks. ...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Myriad Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Myriad Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
